Introduction of breast density notification within BreastScreen South Australia - Results of an online client survey.

Aust N Z J Public Health

BreastScreen SA, Central Adelaide Local Health Network, South Australian Department of Health & Wellbeing, Australia. Electronic address:

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Breast density is one of the strongest predictors of breast cancer risk and significantly reduces the sensitivity of mammography to detect breast cancer. Breast density notification is becoming increasingly common within screening programs in Australia. This opportunistic study evaluates client response to the introduction of breast density notification within BreastScreen South Australia, including their level of understanding, approval of notification and future screening behaviours.

Method: Clients attending three screening clinics (N=14,833) were notified by BreastScreen South Australia of their mammographic breast density, measured by the software program Volpara. Breast density was categorised as follows: A-almost entirely fatty tissue, B-scattered dense tissue, C-heterogeneously dense tissue or D-extremely dense tissue.

Results: Of the 5,137 survey respondents (34.6%), 90% supported continued reporting of breast density in the program. Around two-thirds of respondents (65%) felt informed to make decisions regarding their breast care and nearly all (98.5%) intended to continue breast screening. Anxiety in response to breast density notification was reported by 9% of all respondents (4.5% with breast density categories A/B vs 16.6% with categories C/D) and 14% reported confusion (10.7% with breast density categories A/B vs 19.9% with categories C/D). All notified women were and invited to participate in a follow-up survey to assess their response to breast density notification. Over 22% did not know breast density is associated with breast cancer risk and 55% were unsure.

Conclusion: Breast density notification was well received by most clients; however, knowledge about associated risk is considered low.

Implications For Public Health: Additional new strategies are required to better engage with general practitioners and clients, to improve breast density education and to develop a personalised screening program in the future.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anzjph.2025.100240DOI Listing

Publication Analysis

Top Keywords

breast density
56
density notification
24
breast
18
density
14
breastscreen south
12
south australia
12
breast cancer
12
introduction breast
8
notification breastscreen
8
cancer risk
8

Similar Publications

Nanoscale organization of integrin-mediated receptor crosstalk is crucial for controlling cellular signaling in cancer biology. Previously, interactions between integrin αvβ6 and receptor tyrosine kinases (RTKs) have been implicated in cancer progression, but the spatial regulatory mechanisms remain undefined. Here, we developed a programmable DNA origami-based platform for nanoscale control of heteroligand multivalency and spacing, enabling systematic investigation of αvβ6-RTK interactions in cancer biology.

View Article and Find Full Text PDF

Purpose: Tumor hypoxia is a key barrier to successful delivery and activity of anti-cancer agents. To tackle this, we designed hypoxia-responsive Au-PEI-Azo-mPEG nanoparticles (NPs) denoted as APAP NPs for targeted delivery of hypoxia-activated prodrug (HAP), tirapazamine (TPZ) to hypoxic breast cancer cells.

Methods: AuNPs were first synthesized.

View Article and Find Full Text PDF

This study was conducted in a descriptive and cross-sectional design to determine the physical health status of individuals with substance use disorders receiving inpatient treatment at an addiction treatment center. Data were collected between April 2023 and April 2024 at the Adult Detoxification Center of a psychiatric hospital in Istanbul, Türkiye. The sample consisted of a total of 261 individuals with substance use disorders (218 males and 43 females) who met the inclusion criteria.

View Article and Find Full Text PDF

Do AR and TILs have any association with the efficacy of neoadjuvant treatment for HER2-positive breast cancer?

Medicine (Baltimore)

September 2025

Department of Breast Surgery, Weifang People's Hospital, Weifang, Shandong Province, People's Republic of China.

The presence of androgen receptor (AR) as a marker can be detected in all breast cancer subtypes, and it may provide information on treatment response and prognosis. This study aimed to examine the correlation between AR expression and treatment response in patients diagnosed with human epidermal growth factor receptor 2 (HER2) positive breast cancer who were undergoing neoadjuvant therapy (NAT). The evaluation included breast cancer patients who received NAT and underwent surgery at Weifang People's Hospital's Department of Breast Surgery between October 2019 and October 2022.

View Article and Find Full Text PDF

Introduction: To examine the association of the number of controlled risk factors with the excess risk of severe metabolic dysfunction-associated steatotic liver disease (MASLD) and major adverse liver outcomes (MALO) among patients with type 2 diabetes.

Research Design And Methods: In this cohort study, a total of 307,688 participants from the UK Biobank were included. Participants with baseline type 2 diabetes were categorized according to the number of risk factors within the guideline-recommended ranges (diet, smoking, drinking, exercise, sedentary behavior, body mass index, glycated hemoglobin, blood pressure, and low-density lipoprotein cholesterol).

View Article and Find Full Text PDF